STK11 and neoplasm: Moreover, some clinical researchers demonstrated a significant correlation between STK11 expression and PD-L1 expression in tumor tissues, often showing a lower expression of PD-L1 in patients with STK11mut, providing further evidence that STK11mut may indicate poor immunotherapeutic outcomes [22].